Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.21.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Schedule of cash, cash equivalents and restricted cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same amounts shown in the condensed consolidated statement of cash flows:

 

    March 31,
2021
    December 31,
2020
 
    (in thousands)  
Cash and cash equivalents   $ 164,214     $ 77,068  
Restricted cash     240       240  
Total   $ 164,454     $ 77,308  

  

Schedule of potentially dilutive securities excluded from computation of net loss per share

Potentially dilutive securities (See Note 12 and Note 13) excluded from the computation of basic and diluted net loss per share, as of March 31, 2021 and 2020, are as follows:

 

    2021     2020  
Warrants to purchase common stock     644,906       5,184,210  
Options to purchase common stock     22,983,353       665,536  
Totals     23,628,259       5,849,746